BioNTech SE Announces Collaboration with Bristol Myers Squibb
Ticker: BNTX · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1776985
| Field | Detail |
|---|---|
| Company | Biontech Se (BNTX) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: collaboration, partnership, biotech
TL;DR
BNTX teams up with BMY, details TBD.
AI Summary
On June 2, 2025, BioNTech SE (BNTX) and Bristol Myers Squibb (BMY) announced a collaboration. The specific details of this collaboration, including any financial terms or project scope, are not provided in this filing.
Why It Matters
This announcement signals potential future developments and partnerships for BioNTech, which could impact its research pipeline and market position.
Risk Assessment
Risk Level: low — The filing is an announcement of a collaboration without immediate financial implications or significant new disclosures.
Key Players & Entities
- BioNTech SE (company) — Registrant and collaborator
- Bristol Myers Squibb (company) — Collaborator
- BNTX (company) — Ticker symbol for BioNTech SE
- BMY (company) — Ticker symbol for Bristol Myers Squibb
- June 2, 2025 (date) — Date of announcement
FAQ
What is the nature of the collaboration between BioNTech SE and Bristol Myers Squibb?
The filing announces that BioNTech SE and Bristol Myers Squibb have entered into a collaboration, but does not provide specific details about its nature.
When was this collaboration announced?
The collaboration was announced on June 2, 2025.
Are there any financial terms disclosed for this collaboration?
No financial terms or dollar amounts related to the collaboration are disclosed in this filing.
What are the ticker symbols for BioNTech SE and Bristol Myers Squibb?
The ticker symbol for BioNTech SE is BNTX, and for Bristol Myers Squibb is BMY.
Does this filing provide information on specific projects or research areas for the collaboration?
No, this filing only announces the collaboration and does not specify any projects or research areas.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding BioNTech SE (BNTX).